Therefore, our results suggest that isoproterenol can regulate the proliferation of B16F10 cells by acting on a compartmentalized β2-AR-cAMP-dependent signaling pathway, and that the enhancement of some cAMP pools rather than others may inhibit the growth of B16F10 melanoma. The gene discussed is ADRB2; the disease is melanoma.